Stock Analysis on Net

Boston Scientific Corp. (NYSE:BSX)

This company has been moved to the archive! The financial data has not been updated since May 4, 2023.

Analysis of Long-term (Investment) Activity Ratios 

Microsoft Excel

Long-term Activity Ratios (Summary)

Boston Scientific Corp., long-term (investment) activity ratios

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Net fixed asset turnover 5.18 5.28 4.76 5.16 5.51
Net fixed asset turnover (including operating lease, right-of-use asset) 4.48 4.42 3.90 4.45 5.51
Total asset turnover 0.39 0.37 0.32 0.35 0.47
Equity turnover 0.72 0.72 0.65 0.77 1.13

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Long-term activity ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Boston Scientific Corp. net fixed asset turnover ratio improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022.
Net fixed asset turnover (including operating lease, right-of-use asset) An activity ratio calculated as total revenue divided by net fixed assets (including operating lease, right-of-use asset). Boston Scientific Corp. net fixed asset turnover ratio (with operating lease, right-of-use asset) improved from 2020 to 2021 and from 2021 to 2022.
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Boston Scientific Corp. total asset turnover ratio improved from 2020 to 2021 and from 2021 to 2022.
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. Boston Scientific Corp. equity turnover ratio improved from 2020 to 2021 and from 2021 to 2022.

Net Fixed Asset Turnover

Boston Scientific Corp., net fixed asset turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in millions)
Net sales 12,682 11,888 9,913 10,735 9,823
Property, plant and equipment, net 2,446 2,252 2,084 2,079 1,782
Long-term Activity Ratio
Net fixed asset turnover1 5.18 5.28 4.76 5.16 5.51
Benchmarks
Net Fixed Asset Turnover, Competitors2
Abbott Laboratories 4.76 4.81 3.83 3.97
Cigna Group 47.53 46.73 37.85 34.45
CVS Health Corp. 24.98 22.56 21.25 21.24
Elevance Health Inc. 36.07 34.94 34.69 32.92
Humana Inc. 28.71 26.97 32.05 32.93
Intuitive Surgical Inc. 2.62 3.04 2.76 3.52
Medtronic PLC 5.85 5.77 5.99 6.54
UnitedHealth Group Inc. 31.81 31.81 29.64 27.60
Net Fixed Asset Turnover, Sector
Health Care Equipment & Services 22.49 21.55 20.28 19.95
Net Fixed Asset Turnover, Industry
Health Care 10.62 10.44 9.62 9.73

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Net fixed asset turnover = Net sales ÷ Property, plant and equipment, net
= 12,682 ÷ 2,446 = 5.18

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Boston Scientific Corp. net fixed asset turnover ratio improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022.

Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset)

Boston Scientific Corp., net fixed asset turnover (including operating lease, right-of-use asset) calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in millions)
Net sales 12,682 11,888 9,913 10,735 9,823
 
Property, plant and equipment, net 2,446 2,252 2,084 2,079 1,782
Operating lease right-of-use assets 386 435 458 336
Property, plant and equipment, net (including operating lease, right-of-use asset) 2,832 2,687 2,542 2,415 1,782
Long-term Activity Ratio
Net fixed asset turnover (including operating lease, right-of-use asset)1 4.48 4.42 3.90 4.45 5.51
Benchmarks
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Competitors2
Abbott Laboratories 4.25 4.26 3.42 3.56
Cigna Group 43.23 41.37 33.46 30.72
CVS Health Corp. 10.46 9.09 8.04 7.77
Elevance Health Inc. 31.64 30.12 29.26 27.82
Humana Inc. 24.76 22.09 27.07 27.22
Intuitive Surgical Inc. 2.53 2.93 2.66 3.32
Medtronic PLC 5.06 4.84 5.02 6.54
UnitedHealth Group Inc. 21.54 21.54 19.55 18.97
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Sector
Health Care Equipment & Services 14.87 13.78 12.53 12.33
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Industry
Health Care 8.57 8.28 7.55 7.63

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Net fixed asset turnover (including operating lease, right-of-use asset) = Net sales ÷ Property, plant and equipment, net (including operating lease, right-of-use asset)
= 12,682 ÷ 2,832 = 4.48

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Net fixed asset turnover (including operating lease, right-of-use asset) An activity ratio calculated as total revenue divided by net fixed assets (including operating lease, right-of-use asset). Boston Scientific Corp. net fixed asset turnover ratio (with operating lease, right-of-use asset) improved from 2020 to 2021 and from 2021 to 2022.

Total Asset Turnover

Boston Scientific Corp., total asset turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in millions)
Net sales 12,682 11,888 9,913 10,735 9,823
Total assets 32,469 32,229 30,777 30,565 20,999
Long-term Activity Ratio
Total asset turnover1 0.39 0.37 0.32 0.35 0.47
Benchmarks
Total Asset Turnover, Competitors2
Abbott Laboratories 0.59 0.57 0.48 0.47
Cigna Group 1.25 1.11 1.02 0.98
CVS Health Corp. 1.41 1.25 1.16 1.15
Elevance Health Inc. 1.51 1.41 1.39 1.33
Humana Inc. 2.15 1.87 2.17 2.21
Intuitive Surgical Inc. 0.48 0.42 0.39 0.46
Medtronic PLC 0.35 0.32 0.32 0.34
UnitedHealth Group Inc. 1.31 1.34 1.30 1.38
Total Asset Turnover, Sector
Health Care Equipment & Services 1.22 1.13 1.08 1.07
Total Asset Turnover, Industry
Health Care 0.81 0.76 0.70 0.71

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Total asset turnover = Net sales ÷ Total assets
= 12,682 ÷ 32,469 = 0.39

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Boston Scientific Corp. total asset turnover ratio improved from 2020 to 2021 and from 2021 to 2022.

Equity Turnover

Boston Scientific Corp., equity turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in millions)
Net sales 12,682 11,888 9,913 10,735 9,823
Stockholders’ equity 17,573 16,622 15,326 13,877 8,726
Long-term Activity Ratio
Equity turnover1 0.72 0.72 0.65 0.77 1.13
Benchmarks
Equity Turnover, Competitors2
Abbott Laboratories 1.19 1.20 1.06 1.03
Cigna Group 4.00 3.66 3.16 3.36
CVS Health Corp. 4.53 3.87 3.86 4.00
Elevance Health Inc. 4.29 3.80 3.64 3.25
Humana Inc. 6.04 5.15 5.54 5.35
Intuitive Surgical Inc. 0.56 0.48 0.45 0.54
Medtronic PLC 0.60 0.59 0.57 0.61
UnitedHealth Group Inc. 4.14 3.98 3.90 4.17
Equity Turnover, Sector
Health Care Equipment & Services 3.34 3.03 2.91 2.94
Equity Turnover, Industry
Health Care 2.17 2.10 2.07 2.07

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Equity turnover = Net sales ÷ Stockholders’ equity
= 12,682 ÷ 17,573 = 0.72

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. Boston Scientific Corp. equity turnover ratio improved from 2020 to 2021 and from 2021 to 2022.